Journal of Bone Metabolism最新文献_第9页

The Role of Titanium Particles and Ions in the Pathogenesis of Peri-Implantitis. 钛粒子和离子在种植体周围炎发病机制中的作用。

Journal of Bone Metabolism Pub Date : 2022-08-01 Epub Date: 2022-08-31 DOI: 10.11005/jbm.2022.29.3.145

Farah Asa'ad, Peter Thomsen, Marcel F Kunrath

{"title":"The Role of Titanium Particles and Ions in the Pathogenesis of Peri-Implantitis.","authors":"Farah Asa'ad, Peter Thomsen, Marcel F Kunrath","doi":"10.11005/jbm.2022.29.3.145","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.3.145","url":null,"abstract":"Titanium (Ti) particles and ions have been investigated in recent years as important factors in the pathogenesis of peri-implantitis. However, their role in the pathogenesis is yet to be fully understood. A review of pertinent literature was performed in various databases to determine the current position of Ti particles and ions role in the pathogenesis of peri-implantitis. There are several in vitro, preclinical and clinical published studies that have addressed the role of Ti particles and ions in the pathogenesis of peri-implantitis. These studies explored the effect of Ti particles and ions in the pathogenesis of peri-implantitis with respect to foreign body reaction, cellular response, epigenetic mechanisms, namely DNA methylation, and the oral microbiome. Studies have shown that the release of Ti particles/ions during implant insertion, early healing stages, late healing stages, and treatments during peri-implantitis might contribute to peri-implantitis through different mechanisms, such as foreign body reaction, cellular response, DNA methylation, and shaping the oral microbiome by increasing dysbiosis. However, further studies are needed to elucidate the complex interactions between all these mechanisms and Ti particles/ions in the pathogenesis and progression of peri-implantitis.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 3","pages":"145-154"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/95/jbm-2022-29-3-145.PMC9511127.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33493523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 10

Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea. 韩国修订的抗骨质疏松药物报销指南的效果。

Journal of Bone Metabolism Pub Date : 2022-08-01 Epub Date: 2022-08-31 DOI: 10.11005/jbm.2022.29.3.191

Young-Seung Ko, Yeonsuk Jeong, Jung-Wee Park, Young-Kyun Lee, Kyung-Hoi Koo

{"title":"Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea.","authors":"Young-Seung Ko, Yeonsuk Jeong, Jung-Wee Park, Young-Kyun Lee, Kyung-Hoi Koo","doi":"10.11005/jbm.2022.29.3.191","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.3.191","url":null,"abstract":"Background: The Korean National Health Insurance (NHI) reimbursement guideline was revised in May 2015 with the aim of preventing secondary osteoporotic fractures. Here we compared the: (1) rate of bone mineral density (BMD) measurements; (2) prescription rate of anti-osteoporosis medication within 3 months after hip fracture surgery (HFS); (3) incidence of a second hip fracture; and (4) first-year mortality rate after HFS.Methods: This before-after study used the revised reimbursement system as a reference period. We retrospectively reviewed the medical records of 515 patients who underwent HFS at a tertiary referral hospital between January 2014 and December 2016. The period 1 group underwent HFS in 2014, while the period 2 group underwent HFS in 2016.Results: Despite the fact that there was no significant intergroup difference in BMD measurement rate, the period 2 group had a higher prescription rate for anti-osteoporosis drugs within 3 months of HFS. However, the incidence of a second hip fracture did not differ between groups. The first-year mortality rate was higher in the period 1 versus period 2 group.Conclusions: Revision of the NHI guideline in May 2015 was associated with an increased prescription rate of anti-osteoporosis medication in osteoporotic hip fracture patients.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 3","pages":"191-196"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/82/jbm-2022-29-3-191.PMC9511126.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33480916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women. 促卵泡激素在晚期绝经后妇女骨代谢中的作用。

Journal of Bone Metabolism Pub Date : 2022-08-01 Epub Date: 2022-08-31 DOI: 10.11005/jbm.2022.29.3.175

Chaiho Jeong, Jinyoung Kim, Yejee Lim, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek

{"title":"Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women.","authors":"Chaiho Jeong, Jinyoung Kim, Yejee Lim, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek","doi":"10.11005/jbm.2022.29.3.175","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.3.175","url":null,"abstract":"Background: The effects of elevated follicle-stimulating hormone (FSH) levels on physiological changes in the bone remain unclear. This study aimed to clarify the association between FSH concentrations and bone mineral density (BMD) and bone turnover markers (BTM) in late postmenopausal women.Methods: A total of 169 Korean women were enrolled. The participants' ages ranged from 60 to 84 years (mean age, 69.0±5.1) and reported a mean duration of 19.4±6.6 years since menopause (YSM). The participants showed an average body mass index (BMI) of 24.4±2.8 kg/m2. Age, YSM, estradiol, testosterone, and BMI were confounders in the Pearson's partial correlation. A test for trends across the quartiles of FSH levels was performed for each variable.Results: The mean FSH and estradiol concentrations were 61.5 IU/L and 2.9 pg/mL, respectively. Serum FSH concentration was not significantly associated with BMD (lumbar, r=0.09, P=0.30; total hip, r=0.00, P=0.96; and femoral neck, r=0.05, P=0.62). BTM across the FSH quartiles did not show any trend association (bone-specific alkaline phosphate, P=0.31; crosslinked C-terminal telopeptide of type I collagen, P=0.90). Instead, FSH levels were negatively correlated with BMI (r=-0.34, P=0.00). In the multivariate regression model adjusted for age, testosterone, and estradiol, only BMI showed a negative value across the FSH quartiles (β coefficient -0.11, P=0.00).Conclusions: This study identified that high FSH concentrations were not associated with bone loss or high bone turnover in women in the late postmenopausal period.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 3","pages":"175-183"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/c8/jbm-2022-29-3-175.PMC9511130.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33480914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Parathyroid Crisis as Presentation of Atypical Parathyroid Adenoma: Two Diagnostically Challenging Cases. 甲状旁腺危象作为非典型甲状旁腺腺瘤的表现:两个诊断上具有挑战性的病例。

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.133

Galo Andrés Salvador Landeta, Alexis Trejo Montes, Tania Islem Gamboa Jimenéz, Vargas-Ortega Guadalupe, González-Virla Baldomero, Balcázar-Hernández Lourdes

{"title":"Parathyroid Crisis as Presentation of Atypical Parathyroid Adenoma: Two Diagnostically Challenging Cases.","authors":"Galo Andrés Salvador Landeta, Alexis Trejo Montes, Tania Islem Gamboa Jimenéz, Vargas-Ortega Guadalupe, González-Virla Baldomero, Balcázar-Hernández Lourdes","doi":"10.11005/jbm.2022.29.2.133","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.133","url":null,"abstract":"Atypical parathyroid adenoma (APA) is a rare cause of primary hyperparathyroidism (PHPT) and represents a diagnostic challenge since it is an intermediate form of parathyroid neoplasm of uncertain malignant potential with atypical histological features that require differential diagnosis of parathyroid carcinoma (PC). We present 2 cases of parathyroid crisis as a presentation of APA. The first case was that of a 56-year-old man with parathyroid crisis, constitutional syndrome, and anemia, with evidence of APA after en bloc resection, evolving with hungry bone syndrome after surgery and curation criteria at 6 months after parathyroidectomy (PTX). The second case was a 64-year-old woman with acute chronic kidney disease and parathyroid crisis, with evidence of APA after selective PTX and >50% reduction in parathyroid hormone levels after surgery; however, persistent PHPT at 6 months post-surgery was observed. These cases represented a diagnostic challenge due to their rare clinical presentation (parathyroid crisis), with a heterogeneous spectrum of target organ damage and infrequent symptoms (constitutional syndrome and acute chronic renal disease), in turn caused by a rare pathology (APA). The presentation of these patients may be indicative of PC; however, histopathological diagnosis is a key to the diagnosis of APA. The differential diagnosis of APA vs. PC in clinical practice is indispensable.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"133-140"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/5f/jbm-2022-29-2-133.PMC9208905.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Concerns about Race and Ethnicity within the United States Fracture Risk Assessment Tool. 美国骨折风险评估工具中对种族和民族的关注。

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.141

Martin Mayer, Jon Keevil, Karen E Hansen

引用次数: 2

Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients. 血液透析患者骨髓脂肪、骨密度和Wnt/β-catenin通路抑制剂水平

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.113

Yue-Pei Wang, Nada Khelifi, Cyrille de Halleux, Roth-Visal Ung, France Samson, Claudia Gagnon, Fabrice Mac-Way

{"title":"Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients.","authors":"Yue-Pei Wang, Nada Khelifi, Cyrille de Halleux, Roth-Visal Ung, France Samson, Claudia Gagnon, Fabrice Mac-Way","doi":"10.11005/jbm.2022.29.2.113","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.113","url":null,"abstract":"Background: Marrow adipose tissue (MAT) is known to accumulate in patients with chronic kidney disease. This pilot study aimed to evaluate bone mineral density (BMD), MAT, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) using computed tomography (CT) scans and to explore correlations between bone parameters, circulating Wnt/β-catenin pathway inhibitor levels, and adipose tissue parameters.Methods: Single-center cross-sectional pilot study conducted in hemodialysis patients at the Centre Universitaire de Québec, Hôtel-Dieu de Québec hospital, Canada. CT-scan slices were acquired at the levels of the hip, L3 vertebra, and tibia. Volumetric and areal BMD, tibia cortical thickness, VAT and SAT area, and fat marrow index (FMI) were analyzed using the Mindways QCT Pro software. Blood levels of sclerostin, dickkopf-related protein 1 (DKK1), fibroblast growth factor 23, and α-Klotho were assessed. Spearman's rho test was used to evaluate correlations.Results: Fifteen hemodialysis patients (median age, 75 [66-82] years; 80% male; dialysis vintage, 39.3 [27.4-71.0] months) were included. While inverse correlations were obtained between L3 FMI and BMD, positive correlations were found between proximal tibial FMI and vertebral and tibial BMD, as well as with tibial (proximal and distal) cortical thickness. VAT had a positive correlation with α-Klotho levels, whereas L3 FMI had a negative correlation with DKK1 levels.Conclusions: CT-scan allows simultaneous evaluation of bone and marrow adiposity in dialysis patients. Correlations between MAT and BMD vary depending on the bone site evaluated. DKK1 and α-Klotho levels correlate with adipose tissue accumulation in dialysis patients.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"113-122"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/83/jbm-2022-29-2-113.PMC9208902.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Nutrition and Exercise Treatment of Sarcopenia in Hip Fracture Patients: Systematic Review. 营养和运动治疗髋部骨折患者肌肉减少症:系统综述。

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.63

Jun-Il Yoo, Yong-Chan Ha, Yonghan Cha

{"title":"Nutrition and Exercise Treatment of Sarcopenia in Hip Fracture Patients: Systematic Review.","authors":"Jun-Il Yoo, Yong-Chan Ha, Yonghan Cha","doi":"10.11005/jbm.2022.29.2.63","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.63","url":null,"abstract":"Background: This study aimed to investigate nutritional or rehabilitation intervention protocols for hip fracture patients with sarcopenia and to analyze the effect of these protocols through a systematic review of studies that reported clinical results.Methods: Studies were selected based on the following criteria: (1) study design: randomized controlled trials or non-randomized comparative studies; (2) study population: patients with hip fracture; (3) intervention: nutritional or rehabilitation; and (4) reporting the clinical outcomes and definition of sarcopenia.Results: Of the 247 references initially identified from the selected databases, 5 randomized controlled studies and 2 comparative studies were selected for further investigation. The total number of patients was 497. We found 2 specific rehabilitation interventions, one medication intervention using erythropoietin, and 4 nutritional interventions using amino-acid or protein. Among the studies included in this systematic review, 2 studies did not find a clear statistical difference in assessment tools compared to controls after intervention. On the other hand, the rest of the studies positively interpreted the results for intervention. The most frequently used assessment tool for intervention was handgrip strength.Conclusions: Although mainstream methods of intervention for sarcopenia include nutritional, exercise, and drug interventions, the validity of these interventions in elderly hip fractures has not been clearly proven. In addition, as most studies only reported short-term results, there is no consensus on the optimal long-term treatment.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"63-73"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/83/jbm-2022-29-2-63.PMC9208903.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea. Denosumab在韩国治疗绝经后骨质疏松症的成本-效果

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.83

Jung-Yoon Kang, Leejung Choi, Ben Johnson, Hyowon Yang

{"title":"Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea.","authors":"Jung-Yoon Kang, Leejung Choi, Ben Johnson, Hyowon Yang","doi":"10.11005/jbm.2022.29.2.83","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.83","url":null,"abstract":"Background: Osteoporosis is a progressive skeletal disease associated with an increased risk of bone fracture. This study aimed to estimate the cost-effectiveness of denosumab for osteoporotic fracture prevention compared to bisphosphonates (alendronate, ibandronate, risedronate, and zoledronate) and selective estrogen receptor modulators (raloxifene) in a cohort of postmenopausal women with osteoporosis.Methods: A Markov model was used to evaluate the cost and effectiveness of denosumab versus comparators. The model had a cycle length of 6 months and was run from the age of 68 years to individual patients' lifetime or the age of 100 years. The health states considered in the model were well, hip fracture, vertebral fracture, wrist fracture, other osteoporotic fracture, post-hip fracture, post-vertebral fracture, and death. Recent local data were used as inputs for the model parameters. A discount rate of 4.5% was applied to both costs and outcomes.Results: From the perspective of the healthcare system, denosumab was cost-effective or cost-saving compared to all comparators, considering one unit of Korea's gross domestic product per capita, USA dollar (USD) 34,870. Denosumab was cost-saving compared to ibandronate (oral) and raloxifene. Compared to alendronate, denosumab was cost-effective with an incremental cost-effectiveness ratio (ICER) of USD 767.10 per quality-adjusted life year (QALY). The ICER of denosumab vs. ibandronate IV, risedronate, and zoledronate was USD 685.63, USD 1,469.71, USD 4,668.53 per QALY, respectively.Conclusions: The findings of this analysis suggest that denosumab is a cost-effective therapeutic option for preventing fractures in postmenopausal women with osteoporosis in South Korea.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"83-92"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/86/jbm-2022-29-2-83.PMC9208907.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Moderate-Intensity Exercise Preserves Bone Mineral Density and Improves Femoral Trabecular Bone Microarchitecture in Middle-Aged Mice. 中等强度运动可保持中年小鼠骨密度，改善股骨小梁骨微结构。

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.103

Seungyong Lee, Yun-A Shin, Jinkyung Cho, Dong-Ho Park, Changsun Kim

{"title":"Moderate-Intensity Exercise Preserves Bone Mineral Density and Improves Femoral Trabecular Bone Microarchitecture in Middle-Aged Mice.","authors":"Seungyong Lee, Yun-A Shin, Jinkyung Cho, Dong-Ho Park, Changsun Kim","doi":"10.11005/jbm.2022.29.2.103","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.103","url":null,"abstract":"Background: Aging leads to significant bone loss and elevated osteoporosis risk. Exercise slows age-related bone loss; however, the effects of various moderate-intensity exercise training volumes on bone metabolism remain unclear. This study aimed to determine the degree to which different volumes of moderate-intensity aerobic exercise training influence bone mineral density (BMD), bone mineral content (BMC), femoral trabecular bone microarchitecture, and cortical bone in middle-aged mice.Methods: Twenty middle-aged male C57BL/6 mice were randomly assigned 8 weeks of either (1) non-exercise (CON); (2) moderate-intensity with high-volume exercise (EX_MHV); or (3) moderate-intensity with low-volume exercise (EX_MLV) (N=6-7, respectively). Femoral BMD and BMC were evaluated using dual energy X-ray absorptiometry, and trabecular and cortical bone were measured using micro-computed tomography.Results: Femoral BMD in EX_MHV but not EX_MLV was significantly higher (P<0.05) than in CON. The distal femoral fractional trabecular bone volume/tissue volume (BV/TV, %) was significantly higher (P<0.05) in both EX_MHV and EX_MLV than in CON mice. Increased BV/TV was induced by significantly increased trabecular thickness (mm) and tended to be higher (P<0.10) in BV (mm3) and lower in trabecular separation (mm) in EX_MHV and EX_MLV than in CON. The femoral mid-diaphysis cortical bone was stronger in EX_MLV than EX_MHV.Conclusions: Long-term moderate-intensity aerobic exercise with low to high volumes can be thought to have a positive effect on hindlimb BMD and attenuate age-associated trabecular bone loss in the femur. Moderate-intensity aerobic exercise may be an effective and applicable exercise regimen to prevent age-related loss of BMD and BV.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"103-111"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/86/jbm-2022-29-2-103.PMC9208899.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis. 与唑来膦酸钠治疗相比，Denosumab对绝经后骨质疏松症妇女破骨细胞前体变化的影响。

Journal of Bone Metabolism Pub Date : 2022-05-01 Epub Date: 2022-05-31 DOI: 10.11005/jbm.2022.29.2.93

Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Ae Jin Jeong, Song-Hee Lee, Sang-Kyu Ye, Chan Soo Shin

{"title":"Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.","authors":"Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Ae Jin Jeong, Song-Hee Lee, Sang-Kyu Ye, Chan Soo Shin","doi":"10.11005/jbm.2022.29.2.93","DOIUrl":"https://doi.org/10.11005/jbm.2022.29.2.93","url":null,"abstract":"Background: A rapid increase in bone turnover and bone loss has been observed in response to the discontinuation of denosumab. It led to an acute increase in the fracture risk, similar to that observed in the untreated patients. We aimed to investigate the effect of denosumab on osteoclast (OC) precursor cells compared to that of zoledronate.Methods: The study compared the effects of denosumab (60 mg/24-week) and zoledronate (5 mg/48-week) over 48 weeks in postmenopausal women with osteoporosis. From patients' peripheral mononuclear cells, CD14+/CD11b+/vitronectin receptor (VNR)- and CD14+/CD11b+/VNR+ cells were isolated using fluorescent-activated cell sorting, representing early and late OC precursors, respectively. The primary endpoint was the changes in OC precursors after 48 weeks of treatment.Results: Among the 23 patients, 11 were assigned to the denosumab group and 12 to the zoledronate group (mean age, 69 years). After 48 weeks, the changes in OC precursors were similar between and within the groups. Serum C-terminal telopeptide of type I collagen levels were inversely correlated with OC precursor levels after denosumab treatment (r=-0.72, P<0.001). Lumbar spine, femur neck, and total hip bone mineral density (BMD) increased in both groups. Lumbar spine BMD increased more significantly in the denosumab group than in the zoledronate group.Conclusions: Denosumab and zoledronate treatments induced similar changes in OC precursors. During denosumab treatment, old age and suppressed bone turnover were associated with increased OC precursor cell populations. Further validation studies with prospective designs are required.","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"29 2","pages":"93-101"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/7c/jbm-2022-29-2-93.PMC9208900.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39999039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2